BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 4, 2002
View Archived Issues
Essential Acquiring Maret For 2M Shares Of Locked-Up Stock
Essential Therapeutics Inc. on Friday said it will strengthen its clinical and preclinical pipeline through the acquisition of Maret Pharmaceuticals Inc. in a deal valued at up to about $6.8 million. (BioWorld Today)
Read More
Titan Cancer Antibodies Paired In Colorectal Phase II Study
Read More
KO Mice Answer In Affirmative; Ablation Of Muc2 Gene Results In Full-Blown Colorectal Cancers
Read More
Peregrine, Oxigene End Venture On Vascular Targeting Agents
Read More
InterMune Goes To Shelf, Files To Sell 2.5M Shares
Read More
Other News To Note
Read More